Investors are eyeing Pfizer Inc. at 52-week lows, optimistic about improving pipeline and revenue growth.

From Yahoo Finance: 2025-03-30 08:47:00

In 2025, S&P 500 entered market correction territory for the first time since 2023 due to new trade policies and economic uncertainty related to tariffs. Technology sector underperformed, dragging the market down, while global stocks showed positive returns despite early 2025 struggles. Uncertainty remains a key driver in the market decline.

US markets fluctuated in Q1 2025, with S&P 500 gaining 4.5% by February 19 but down 3.23% YTD through March 17. Despite the uncertainty, underlying fundamentals remain positive, with consumers in a good spot and companies flush with cash. Global stocks delivered positive returns, offering opportunities for investors in a diverse portfolio.

Pfizer Inc. (PFE) is among the Blue Chip Stocks to Invest in at 52-Week Lows, trading at $25.55 as of March 25, with a 52-week low of $24.48. The company focuses on improving R&D pipeline productivity and achieved revenue growth in FY 2024. PFE ranks 1st on the list, but undervalued AI stocks may offer higher returns within a shorter timeframe.

Read more: Among Blue Chip Stocks to Invest in at 52-Week Lows